Rheumatology Grand Rounds: Clinical Characteristics of Neutralizing Antibodies in Recovered COVID-19 Patients

Friday, May 15, 2020, 12:00 AM - Saturday, May 15, 2021, 12:00 AM

Internet Enduring Material sponsored by the Stanford University School of Medicine.

This video session is designed to update members of the healthcare team on neutralizing antibody responses to SARS-CoV-2 in recovered patient cohort and their implications. 
Faculty will discuss neutralizing antibodies and viral clearance and ability to block viral infection. Level has been used as gold standard for efficacy of vaccines against smallpox, polio, influenza
Determined that most patients in study developed CoV-2 NAB in the convalescent phase of infection. Take away thoughts: Unclear role of neutralizing antibodies on disease progression, correlation between age, lymphocyte counts, and blood CRP levels. Titration of neutralizing antibody may be helpful prior to use of convalescent plasma given variability.

  Release Date: May 15, 2020
  Expiration Date: May 15, 2021
  Estimated Time to Complete: 46 minutes
  CME Credits Offered: 0.75
  Registration Fee: FREE

*Originally recorded 04/30/2020, as a Stanford Rheumatology Grand Rounds.

AMA PRA Category 1 Credits™ (0.75 hours), Non-Physician Participation Credit (0.75 hours)

1. Discuss clinical characteristics of neutralizing antibodies in recovered COVID 19 patients
2. Explore potential use of neutralizing antibodies

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation American Medical Association (AMA) Stanford Medicine designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. 

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Reference/Bibliography List
COVID-19 CME Resources https://med.stanford.edu/cme/COVID19.html

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.   There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.